Can anti-parasitic drugs help control COVID-19?

Author:

Panahi Yasin1ORCID,Dadkhah Masoomeh2ORCID,Talei Sahand3ORCID,Gharari Zahra4ORCID,Asghariazar Vahid5ORCID,Abdolmaleki Arash67ORCID,Matin Somayeh8,Molaei Soheila29ORCID

Affiliation:

1. Department of Pharmacology & Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran

2. Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

3. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4. Department of Biotechnology, Faculty of Biological Sciences, Al-Zahra University, Tehran, Iran

5. Deputy of Research & Technology, Ardabil University of Medical Sciences, Ardabil, Iran

6. Department of Engineering Sciences, Faculty of Advanced Technologies, University of Mohaghegh Ardabili, Namin, Iran

7. Bio Science & Biotechnology Research center (BBRC), Sabalan University of Advanced Technologies (SUAT), Namin, Iran

8. Department of Internal Medicine, Imam Khomeini Hospital, Ardabil University of Medical Sciences, Ardabil, Iran

9. Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

Abstract

Novel COVID-19 is a public health emergency that poses a serious threat to people worldwide. Given the virus spreading so quickly, novel antiviral medications are desperately needed. Repurposing existing drugs is the first strategy. Anti-parasitic drugs were among the first to be considered as a potential treatment option for this disease. Even though many papers have discussed the efficacy of various anti-parasitic drugs in treating COVID-19 separately, so far, no single study comprehensively discussed these drugs. This study reviews some anti-parasitic recommended drugs to treat COVID-19, in terms of function and in vitro as well as clinical results. Finally, we briefly review the advanced techniques, such as artificial intelligence, that have been used to find effective drugs for the treatment of COVID-19.

Publisher

Future Medicine Ltd

Subject

Virology

Reference225 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3